PRECISIONscientia MM+M Awards 2022 Finalist

PRECISIONscientia Voted a 2022 MM+M Awards Finalist in Data Platform Category for DOL Map

This MM+M award recognizes PRECISIONscientia’s state-of-the-art, proprietary digital opinion leader (DOL) data platform, DOL Map. This platform is a unique and innovative means for pharma to identify, track, and engage hard-to-find DOLs in their respective disease areas. DOL Map uses artificial intelligence to parse through millions of social media conversations to find the most impactful DOLs. Our unique tool is especially helpful for companies developing and marketing drugs for more obscure diseases, with communities that are less likely to include famous TikTok doctors with millions of followers and flashy viral videos.

Not only does DOL Map identify who is doing the talking, but it also analyzes who they are talking to, how often people are sharing their posts, and how relevant the discussion is to the disease area. Therefore, a researcher who is followed by a high percentage of other doctors and is tweeting about medical congresses related to the disease would be flagged as a potential DOL worth engaging. After identifying a list of the top DOLs for a client’s requested area, the platform then displays those experts in a dashboard that keeps track of their online activity in real time.

By working with trusted DOLs, pharma companies can also help overshadow much of the false information that abounds on social media by steering patients toward credible sources for information.

MM+M Awards recognize, champion, and celebrate creativity and effectiveness in health care marketing and communications. An MM+M Award is valued because recognition comes from industry peers. This year’s MM+M Awards will be a hybrid event taking place on October 6, with the in-person element returning to Cipriani Wall Street. We are honored to be a finalist and look forward to October 6th awards.

Data Platform Finalists

  • PRECISIONscientia, Comprehensive DOL Profiling & Mapping
  • Indegene, Integrated Data Platform to Enable Rich Patient Insights 
  •, Using AI and Machine Learning to Uncover Undiagnosed Patients with Rare Diseases   
  • NYU Langone Health and Deloitte Digital, The Return Visit  
  • ViiV Healthcare, Entree Health, and Access insight, One Step Closer to Ending the HIV Epidemic

See the full list of MM+M Awards

Read more about our DOL Map tool and all KOL Data Solutions

The Precision Value & Health family of brands is now Precision AQ

Precision AQ helps life sciences companies navigate the complexities of commercialization across a product’s lifecycle. Our team is comprised of experts, advisors, and creators working to ensure patients have access to life-changing medicines.

Our global offerings include:

  • Commercialization research, strategy and product planning
  • HEOR
  • Market access
  • Advertising, Branding & PR
  • Medical communications
  • Investor relations and external communications
  • Learning & development
  • Data and product solutions (Access Genius, Navigator365, OncoGenius, EHR Solutions, KOL/DOL Map)

Our name, which stands for Precision Access Quotient, reflects our approach to removing barriers – fusing together science (IQ, or Intelligence Quotient) and empathy (EQ, or Emotional Quotient). The result is “AQ: Access Quotient”, a critical ingredient in navigating the therapy-to-patient journey informed by data-driven analytics and insights.

To find out more about our global services and our unified mission, empowering access to life-changing medicines for all, visit: Precision AQ


Accelerating clinical research and development through the combined power of trials, labs, and data science.

Demonstrating the value of life-science innovations with evidence and real-world expertise.